Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Threat Reversal Abnormality and Underlying Neural Mechanisms in Patients With Anxiety Disorders

NCT06232369 is registered in ClinicalTrials.gov with Shenzhen Kangning Hospital as lead sponsor.

NCT NCT06232369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Threat Reversal Abnormality and Underlying Neural Mechanisms in Patients With Anxiety Disorders
Lead sponsor
Shenzhen Kangning Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2024
Completion date
September 30, 2025
Enrollment
190 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, anxiety state